
Why earwax can predict if you're at risk of developing Parkinson's disease
Published: | Updated:
Scientists have revealed that the wax in your ears could actually say a lot about your health.
Researchers in China have identified key differences in the makeup of earwax in people with Parkinson's disease compared to people without the condition, suggesting the sticky stuff holds secrets that could flag a person's risk of eventually developing the condition.
Scientists at Zhejiang University took earwax samples from 100 people with Parkinson's and 79 without. They chose earwax because much of it is made up of sebum, an oily substance that undergoes chemical changes in cases of Parkinson's, and releases distinct volatile organic compounds (VOCs).
Parkinson's triggers neurodegeneration, inflammation, and oxidative stress, altering sebum's composition and creating a distinct odor.
It also progressively damages the brain, causing tremors, stiffness, and slow movement.
Over time, symptoms worsen to include sudden freezing, speech loss, swallowing problems -often leading to pneumonia - and falls, both common causes of death among people with Parkinson's.
Four specific types of VOCs stood out among people with the condition, suggesting that earwax could potentially be an accessible indicator of Parkinson's, which would allow patients to avoid invasive diagnostic tests and spinal taps.
Around 1million Americans and 10million people globally currently have the disease, with nearly 90,000 new cases diagnosed each year. As that number is projected to climb, early diagnosis is more important than ever. While there is no cure, medication regimens can be started early to treat symptoms and slow down the progression of the disease.
Researchers fed the VOC data from the samples of earwax into an algorithm that categorized subjects' Parkinson's status accurately 94 per cent of the time, demonstrating the potential for a fast, reliable diagnostic tool.
The VOCs that stood out to researchers were all significant in differentiating between people with the condition and those without it, even after accounting for age and lifestyle factors.
Two of the VOCS, Ethylbenzene & 4-Ethyltoluene, are compounds commonly found in plastics and petroleum products.
Their presence suggests inflammation in the brain, which is a key driver of the breakdown of dopamine in the brain.
Dopamine, while often thought of as a 'feel good' neurotransmitter, is a key chemical messenger that regulates movement control.
As dopamine levels plummet while Parkinson's progresses, people become steadily more immobile.
Another significant VOC was Pentanal, which is produced when fats break down.
Elevated levels suggest cell damage, a hallmark of Parkinson's. The compound has been linked to an accumulation of protein clumps in patients' brains.
And the VOC 2-Pentadecyl-1,3-dioxolane likely reflects issues with the metabolism of fats, which could have originated from microbiome changes in the skin of patients.
It's unclear whether this VOC has any direct links to PD, but there is an expanding body of research pointing to a connection between PD and an imbalance in the gut microbiome.
Soaring: Parkinson's death rates rose from 42 to 65 deaths per 100,000 from 1999–2017
Research suggests that VOCs are produced by the balance of good bacteria in the gut, which have also been associated with brain health.
An imbalance allows harmful bacteria to flourish, leading to a proliferation of toxins that can cause inflammation in the brain.
VOCs come from a wide array of toxic sources in the environment, from pesticides used to grow food, industrial chemicals in gasoline, and solvents in everyday items like dry cleaning chemicals and adhesives, to cleaning products, car emissions, and contaminated groundwater.
Parkinson's is believed to be caused by a confluence of genetic and environmental factors.
It is the world's fastest-growing brain disorder, and, according to NIH research, 'exposure to environmental toxicants is the principal reason.'
In the US, deaths from Parkinson's disease have more than doubled in the past 20 years, with about 35,000 deaths in 2019 compared to 14,500 in 1999.
While considering the clues that earwax can provide about Parkinson's development is new, investigating the role that VOCs play is not.
A sweeping 2023 meta-analysis identified distinct VOCs present in the breath and skin oil in people with the disease compared to those without it.
These compounds are specifically linked with oxidative stress, or a barrage of damage that cells endure before dying.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BreakingNews.ie
3 hours ago
- BreakingNews.ie
Mother relives shock of life-changing stroke just days after son was born
A mum has relived the shock of a life-changing stroke just days after she brought her newborn son home from hospital. Lisa Kenny, 42, was separated from her family for seven months after the crippling health emergency derailed the joy of welcoming baby Alfie in October 2019. Advertisement She now lives with aphasia, an acquired language disorder that often occurs following brain injury, such as stroke. She spoke about her experience as part of Aphasia Awareness Month. Aphasia affects the understanding of spoken or written language, including reading and writing or the production of spoken language. Mother of two Lisa Kenny, 42, pictured with baby Alfie in hospital after suffering a stroke within a week of his birth in 2019. Picture: Emma Kenny. Ms Kenny, from Balbriggan in north Dublin, said: 'With my stroke and aphasia, it was hard to suddenly be separated from my children because I couldn't talk and I was on a lot of medication. Advertisement 'When I was in hospital, it was so hard because I couldn't see my children, Emily, now 13, and Alfie.' Her first symptom of stroke, four days after returning home with Alfie, was a headache and she later lost feeling in her right arm and leg before her face began to droop. Ms Kenny's fiance, Paul, phoned for an ambulance and a brain scan revealed she had experienced a haemorrhagic stroke. She underwent brain surgery and again two months later, to replace her skull bone. Advertisement Due to complications including pneumonia and seizure, it would be seven months before Lisa she could return home from the National Rehabilitation Hospital, where she worked with occupational, physical and speech and language therapists. 'Now, I'm OK with speaking and talking, it's 50/50. I have got back to normal texting, which is huge for my communication,' she said. As a result of her aphasia, she could not return to work. Lisa uses Irish Heart Foundation supports to aid her recovery, including the Young Stroke Survivors Network, the Life after Stroke private Facebook group, the Aphasia-Friendly Cafe and the Rhythm of Recovery Choir. Advertisement 'I continue to push and challenge myself and just try to stay positive,' she said. 'I keep going, keep strong and healthy, for Emily and Alfie. 'I choose to laugh, love and be happy because life keeps going on and I will always have them with me. 'My speech and language and physiotherapy are the key, too.' Advertisement She is working with the national charity to improve her comprehension, reading and maths. Helen Gaynor, head of community support services with the charity, said: 'The Irish Heart Foundation offers a variety of support services for people living with the life changing effects of a stroke, including the challenges of aphasia. 'Our stroke connect service and peer support groups are available to anyone who has experienced a stroke, and those living with aphasia. 'Our Step by Step through Stroke booklet, a helpful guide for stroke survivors, families and carers, helps people to prepare for potential changes due to stroke, such as communication difficulties.' For more information on aphasia support, and other supports for anyone affected by heart disease or stroke, visit


BBC News
3 hours ago
- BBC News
How dem make anti-venom from man wey snake bite 200 times
Di blood of one US man wey deliberately inject imsef wit snake venom for nearly twenty years don lead to "unparalleled" anti-venom, scientists tok. Antibodies find in Tim Friede blood don shown to protect against deadly doses from one wide range of species in animal tests. Current therapies gatz match di specific species of venomous snake wey bite anyone. But Oga Friede 18-year mission fit lead to ogbonge step of finding universal anti-venom against all snakebites - wey dey kill up to 140,000 pipo evri year and leave three times as many needing amputations or facing permanent disability. In total, Mr Friede don endure more dan 200 bites and more dan 700 injections of venom e prepare from some of di world deadliest snakes, including multiple species of mambas, cobras, taipans and kraits. E bin want build up im immunity to protect imsef wen e dey handle snakes, documenting im exploits on YouTube. But di former truck mechanic tok say e don "completely screw up" early on wen two cobra bites wey happun in quick succession leave am in coma. "I no wan die. I no wan lose one finger. I no wan miss work," e tell BBC. Oga Friede motivation na to develop beta therapies for di rest of di world, explaining: "E just become lifestyle and I just keep pushing and pushing and pushing as hard as I fit push - for di pipo wey dey 8,000 miles away from me wey don die from snakebite". 'I go love to get my hands on some of your blood' Currently dem dey make anti-venom by injecting small doses of snake venom into animals, such as horses. Dia immune system dey fight di venom by producing antibodies and dem go harvest am to use as therapy. But venom and anti-venom gatz dey closely matched becos di toxins for venomous bite no be di same from one species to anoda. Dem even get wide variety within di same species – anti-venom wey dem make from snakes from India dey less effective against di same species for Sri Lanka. One team of researchers begin dey search for one type of immune defence wey dem dey call broadly neutralising antibodies. Instead of targeting di part of toxin wey make am unique, dem dey target di part wey make am common to entire classes of toxin. Dat na wen Dr Jacob Glanville, chief executive of biotech company Centivax, come across Tim Friede. "Immediately I look say 'if anybody in di world don develop dis broadly neutralising antibodies, e go be am' and so I reach out," e tok. "Di first call, I be like 'dis fit dey awkward, but I go love get my hands on some of your blood'." Oga Friede agree and di work dey ethically approved becos di study go only take blood, rather dan give am more venom. Di research focus on elapids – one of di two families of venomous snakes – such as coral snakes, mambas, cobras, taipans and kraits. Elapids primarily use neurotoxins in dia venom, wey dey paralyse dia victim and e dey fatal wen dem stop di muscles e need to breathe. Researchers don pick 19 elapids identify by di World Health Organization as being among di deadliest snakes on di planet. Dem don begin to source for Oga Friede blood for protective defences. Dia work, dey detailed in di journal Cell, identify two broadly neutralising antibodies wey fit target two classes of neurotoxin. For experiments on mice, di cocktail mean say di animals bin survive deadly doses from 13 of di 19 species of venomous snake. Dem bin get partial protection against di remaining six. Dis na "unparalleled" breadth of protection, according to Dr Glanville, wey say e "likely cover a whole bunch of elapids for wey no get current anti-venom". Di team dey try to refine di antibodies further and see if adding fourth component fit lead to total protection against elapid snake venom. Di oda class of snake – di vipers – dey rely more on haemotoxins, wey dey attack di blood, rather dan neurotoxins. In total around one dozen broad classes of toxin in snake venom, wey also include cytotoxins dey directly kill cells. "I think in di next 10 or 15 years we go get somtin effective against each one of dis toxin classes," Prof Peter Kwong, one of di researchers for Columbia University, tok. And di hunt continue inside Oga Friede blood samples. "Tim antibodies dey really quite extraordinary - e bin teach im immune system to get dis veri, veri broad recognition," Prof Kwong tok. Di ultimate hope na to get either single anti-venom wey fit do evritin, or one injection for elapids and one for vipers. Prof Nick Casewell, na di head of di centre for snakebite research and interventions for di Liverpool School of Tropical Medicine - e tok say di breadth of protection report bin dey unusual and provide "strong piece of evidence" wey get feasible approach. "No doubt say dis work move di field forward in exciting direction." But e caution say "plenti work still dey to do" and di anti-venom still go need extensive testing bifor dem fit use am in pipo. But for Oga Friede, reaching dis stage "make me feel good". "I dey do somtin good for humanity and e bin dey veri important to me. I dey proud of am. E dey pretty cool."


Daily Mail
12 hours ago
- Daily Mail
How to tell if your crusty brown skin patch is something sinister... and when you should call the doctor - by top skin expert AENONE HARPER-MACHIN
As the human body's largest organ, it's no surprise that an endless number of things can go wrong with your skin. There are the lumps and bumps that can appear out of nowhere, the myriad of shapes and colours of moles, freckles, warts and patches of skin which may turn darker or become dry and crusty.